The results of curve fitting analysis. by Hai-bo Ai (20790405)

The aging parameters of each group of batteries. by Peijian Jin (22265437)

Subjects:

The peak frequency of the two waveforms of the acoustic emission signal of batteries. by Peijian Jin (22265437)

Subjects:

Connection of lithium-ion battery acoustic emission experimental equipment. by Peijian Jin (22265437)

Subjects:

Waveform time interval in the 0.5C discharge stage of each group. by Peijian Jin (22265437)

Subjects:

Capacity curve of lithium-ion battery cyclic aging. by Peijian Jin (22265437)

Subjects:

Waveform time interval in the 1C discharge stage of each group. by Peijian Jin (22265437)

Subjects:

Flowchart of the extraction of the peak frequencies of the two waveforms. by Peijian Jin (22265437)

Subjects:

Minimal data set. by Peijian Jin (22265437)

Subjects:

Battery parameters. by Peijian Jin (22265437)

Subjects:

Battery voltage changes during discharge and charge. by Peijian Jin (22265437)

Subjects:

Burst acoustic emission signal recorded in continuous acquisition mode. by Peijian Jin (22265437)

Subjects:

Signal time interval in the 0.5C discharge stage of each group. by Peijian Jin (22265437)

Subjects:

Experimental lithium-ion batteries. by Peijian Jin (22265437)

Subjects:

Schematic diagram of two time intervals. by Peijian Jin (22265437)

Subjects:

Acoustic emission experimental scheme for lithium-ion batteries. by Peijian Jin (22265437)

Subjects:

Mechanism of acoustic emission dual waveform signal formation. by Peijian Jin (22265437)

Subjects:

Comparison of acoustic emission signal before and after noise reduction. by Peijian Jin (22265437)

Subjects:

Signal time interval in the 1C discharge stage of each group. by Peijian Jin (22265437)

Subjects:

Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration: by Vidya G. Bettada (22208808)

“…Administration of cisplatin (2.5 mg/Kg) and vitamin D3 (125 µg/Kg) significantly decreased the vessel density (CD31) compared to the tumor control group.…”